Homologous sequence in lumican and fibromodulin LRR 5-7 competes for collagen binding.

    Research output: Contribution to journalArticlepeer-review

    67 Citations (SciVal)


    Lumican and fibromodulin compete for collagen type I binding in vitro and fibromodulin-deficient mice have four-fold more lumican in tendons. These observations indicate that homologous sequences in lumican and fibromodulin bind to collagen type I. Here, we demonstrate that lumican binding to collagen type I is mediated mainly by Asp-213 in LRR 7. The mutation D213N in lumican impairs interaction with collagen, and the lumican fragment spanning LRRs 5-7 is an efficient inhibitor of collagen binding. Also, the lumican LRR 7 sequence-based synthetic peptide CYLDNNKC inhibits the binding to collagen. Homologous collagen-binding site in fibromodulin, located in LRRs 5-7, inhibits the binding of lumican to collagen, and the mutation E251Q in this fibromodulin fragment does not inhibit the lumican-collagen binding. Lumican, but not the the D213N mutation, lowers the melting point and affects the packing of collagen fibrils.
    Original languageEnglish
    Pages (from-to)534-539
    JournalJournal of Biological Chemistry
    Issue number1
    Publication statusPublished - 2009

    Subject classification (UKÄ)

    • Cell and Molecular Biology


    Dive into the research topics of 'Homologous sequence in lumican and fibromodulin LRR 5-7 competes for collagen binding.'. Together they form a unique fingerprint.

    Cite this